Clinical Trials
17 trialsNCT05932758 2023-07-21
Excisional Vacuum-Assisted Breast Biopsy
European Institute of Oncology
Phase NA Unknown
NCT05868252 2023-05-22
Molecular Analysis of the Sloane Project
King's College London
Unknown
NCT00470236 2023-03-22
DCIS
Trans Tasman Radiation Oncology Group
Phase NA Unknown
NCT02909426 2021-10-07
MUST-BE
Soonchunhyang University Hospital
Unknown
NCT03109522 2020-02-21
ARM
McMaster University
Phase NA Unknown
NCT04046159 2019-08-06
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
National Taiwan University Hospital
Phase 3 Unknown
NCT03543397 2018-06-01
MRI in Ductal Carcinoma in Situ (DCIS)
University Hospital, Strasbourg, France
Unknown
NCT02617082 2015-11-30
Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery
Fudan University
Unknown
NCT00967239 2015-05-08
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Unknown
NCT02389686 2015-03-17
Intra-operative Radiotherapy For Breast Cancer Women After NSM
Guangdong Academy of Medical Sciences
Phase NA Unknown
NCT00671476 2014-01-10
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
National Cancer Institute (NCI)
Phase NA Unknown
NCT00126464 2013-11-06
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
National Cancer Institute (NCI)
Phase NA Unknown
NCT00935233 2013-08-12
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
National Cancer Institute (NCI)
Unknown
NCT01185145 2013-07-11
APBI
Rocky Mountain Cancer Centers
Phase 2 Unknown
NCT01034891 2009-12-18
WAR
New York Presbyterian Hospital
Unknown
NCT00077168 2009-02-09
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00669747 2008-10-02
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Windy Hill Medical, Inc.
Phase 2 Unknown